Circulating Immune Proteins in Liver Cancer Research
Fill out the form below, and we shall send your colleague an invitation to the "Circulating Immune Proteins in Liver Cancer Research" event.
Inflammation and immune signaling are closely linked to hepatobiliary cancer development, yet distinguishing biomarkers of cancer risk from underlying liver disease remains a major research challenge.
This webinar explores how circulating immune-related proteins can improve our understanding of hepatocellular and gallbladder cancer risk across diverse populations with viral hepatitis.
Attendees will learn how large-scale protein profiling supports biomarker discovery, risk stratification, and investigations of disease mechanisms while highlighting the importance of considering fibrosis, infection status, ancestry, and other sources of biological variation in translational cancer research.
Attend this webinar to:
- Understand how inflammation and immune signaling contribute to hepatobiliary cancer development
- Recognize the relevance of profiling circulating immune-related proteins to identify potential biomarkers of cancer risk
- Discover that biomarker associations may differ across patient subgroups and clinical contexts
- Learn how Olink-based protein profiling can be applied to biomarker discovery and research on risk stratification
